Progress in research on the anti-tumor effect of Artesunate

Chinese Journal of Integrative Medicine

Volumn 14, Issue 4, 2008, Pages 312-316

  He, Rong Rong ^a   Zhou, Huai Jun ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Angiogenesis; Artesunate; Cell apoptosis; Tumor

Indexed keywords

ARTESUNATE; CASPASE 3; CELL NUCLEUS ANTIGEN; DNA POLYMERASE; FREE RADICAL; INTERCELLULAR ADHESION MOLECULE 1; IRON; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER RESEARCH; CANCER THERAPY; CELL CYCLE ARREST; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY; TUMOR VASCULARIZATION;

AMEBICIDES; ANIMALS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; FREE RADICALS; HUMANS; IMMUNOSUPPRESSION; IRON; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED;

EID: 57749208718     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-008-0312-0     Document Type: Review

References (30)

1. Yang CP, Wan HJ. Research progress in antitoxoplasmic effect of arternisinin and its derivatives. Int J Med Parasit Dis (Chin) 2006;33(3):160-162.
2. Ye OX, Lu X. Research progress in antitumor of arternisinin and derivatives. J Pract Med (Chin) 2006;22(5):600-601.
3. Efferth T, Dunstan H, Sauerbrey A, et al. The anti-malarial artesunate is also active against cancer. Int J Oncol 2001;18(4):767-773.
4. Liu X, Li Y, Xu GL, et al. Effects of artesunate on K562 cell apoptosis and Fas/FasL expression of chronic granulocytic leukemia. Shanghai J Tradit Chin Med (Chin) 2006;40(10):63-65.
5. Li PC, Lam E, Roos WP, et al. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 2008;68:4347-4351.
6. Li LN, Zhang HD, Yuan SJ, et al. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int Cancer 2007;121:1360-1365.
7. Zhang YC, Yu SH, Zhang YH, et al. Percutaneous transhepatic injection of artesunate by ultrasonic guidance in treating primary hepatic carcinoma 15 cases. J Clin Med Pract (Chin) 2007;11(3):64-67.
8. Zhang ZY, Yu SQ, Miao LY, et al. Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: A randomized controlled trial. J Chin Integr Med (Chin) 2008;6(2):134-138.
9. Chen LJ, Jin QY, Yu LR, et al. Research progress on antitumor of arternisinin and derivatives. Chin Tradit Herb Drugs (Chin) 2005;36(11):1754-1755.
10. Wang J, Liu L, Li JM, et al. The inhibitory effect of artesunate on human esophageal carcinoma is associated with modulation of CDC25A and TGFp. Tumor (Chin) 2007;27(4):272-276.
11. Zhang X, Yang XP, Pan QC. Studies on the antitumor effect and apoptosis induction in human liver cancer cell line (BEL-7402) by sodium artesunate. Chin Tradit Herb Drugs (Chin) 1998;29(7):467-469.
12. Li Z, Yuan SJ, Nie LP, et al. Apoptosis of tumor cells induced by artesunate is associated with suppressing survivin expression. Chin J Clin Pharmacol Ther (Chin) 2004;9(6):607-611.
13. Wu LM, Zhao Y, Wang Q, et al. Preliminary mechanism of artesunate treating hepatocarcinoma. China J Basic Med Tradit Chin Med (Chin) 2002;8(8):33-34.
14. Zhang YC, Chen SY, Zhang YL. Effects of artemisunate on expression of intercellular adhesion molecule-1 in human colon cancer line HCT116. Chin J Clin Med (Chin) 2006;13(5):775-776.
15. Ai JX. Inhibiting effect of artemisinin on Hela cell growth. J Shanxi Med Univ (Chin) 2007;38(3):204-207.
16. Efferth T, Giaisi M, Merling A, et al. Artesunate induce ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS ONE 2007;2(1):e693.
17. Wang YY, Song XF, Cui XJ, et al. Apoptosis induced by artesunate in human adenocarcinoma cell line A549 cells associated with activation of caspase-9 and caspase-3. Cancer Res Prev Treat 2007;34(9):651-653.
18. Kelter G, Steinbach D, Konkimalla VB, et al. Role of transferrin receptor and the ABC transporters ABC66 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS ONE 2007;2(8):e798.
19. Wang WQ, Zhou HJ, Chen HH, et al, Inhibitory effect of artesunate on angiogenesis. Chin J Pharmacol Toxicol (Chin) 2004;18(1):32-36.
20. Chen HH, Zhou H J, Wu GD, et al. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular enclothelial growth factor and VEGIF receptor KDR/flk-1. Pharmacology 2004;71(1):1-9.
21. Zhou HJ, Wang WQ, Wu GD, et al. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vascul Pharmacol 2007;47(2-3):131-138.
22. Lee J, Zhou HJ, Wu XH. Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Cancer Chemother Pharmacol 2006;57:213-220.
23. Dell' Eva R, Pfeffer U, Vene R, et al. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 2004;68:2359-2366.
24. Lewis MP, Lygoe KA, Nystrom ML, et al. Tumour-derived TGF-betal modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004;90:822-832.
25. Hsiao YW, Liao KW, Hung SW, et al. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta and restores the lymphokine-activated killing activity. J Immunol 2004;172(3):1508-1514.
26. Kim ES, Kim MS, Moon A. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 2005;29:84-91.
27. Cui C, Wang RT, Tong H, et al. Influence of artesunate and oxymatrine on the immunosuppressive effect of mouse colon-rectal carcinoma cell line Colon 26. Current Immun (Chin) 2006;26(2):152-156.
28. Liu XY, Wang RT, Wang ZH, et al. Artesunate reverses immunosuppresion of L929 tumor cells. Chin J Immun (Chin) 2007;23(11):985-988.
29. Liu W, Chen H, Xiang JY. Effects of artesunate on the proliferation of human laryngocarcinoma Hep-2 cell line and MEK/ERK, NF- κ B signaling pathway. Herald Med (Chin) 2007;26(11):1267-1269.
30. Zhang JX, Wang SX, Zhang FG, et al. Primary study of effect of hypoxic killing and radiation sensitivity of arternisinin on human cervical cancer cell. Chin J Cancer (Chin) 2001;20(12):1363-1366.